Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Columbia University
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Societe Internationale d'Oncologie Pediatrique
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
NYU Langone Health
Dana-Farber Cancer Institute
Mayo Clinic
Mayo Clinic